The elevation of IGF-I and IGF-1R and their resultant interaction appears to up-regulate the PI3K/AKT/NF-κB pathway with the concomitant activation of ZEB2 and SNAIL1, altering protein expression and the EMT phenotype in certain lung cancers [67]. The gene discussed is IGF1; the disease is lung cancer.